Showing results (241-250 of 339) with videos related to
Sort By:
Pageof 34
Organic Letters|February 9, 2019
Cystobactamids 920-1 and 920-2: Assignment of the Constitution and Relative Configuration by Total SynthesisTherese Planke, María Moreno, Stephan Hüttel, et al.The EMBO Journal|June 22, 2023
YTHDF2/m<sup>6</sup> A/NF-κB axis controls anti-tumor immunity by regulating intratumoral TregsLinda Zhang, Xiaoyang Dou, Zhong Zheng, et al.Journal of Cachexia, Sarcopenia and Muscle|January 29, 2020
The mechanisms and treatments for sarcopenia: could exosomes be a perspective research strategy in the future?Shuang Rong, Liangliang Wang, Zhao Peng, et al.Scientific Reports|October 25, 2016
Proteomic and phosphoproteomic analysis of renal cortex in a salt-load rat model of advanced kidney damageShaoling Jiang, Hanchang He, Lishan Tan, et al.Journal of Medicinal Chemistry|November 3, 2021
Immune Modulating Antibody-Drug Conjugate (IM-ADC) for Cancer ImmunotherapyLei He, Liangliang Wang, Zhisong Wang, et al.Gut|March 9, 2021
<i>Lactobacillus rhamnosus</i> GG induces cGAS/STING- dependent type I interferon and improves response to immune checkpoint blockadeWei Si, Hua Liang, Jason Bugno, et al.Journal of Bacteriology|January 18, 2018
Assembly of Methyl Coenzyme M Reductase in the Methanogenic Archaeon Methanococcus maripaludisZhe Lyu, Chau-Wen Chou, Hao Shi, et al.Molecular and Cellular Biochemistry|June 22, 2010
Identification of novel transcripts from the porcine MYL1 gene and initial characterization of its promotersFei Ling, Wei Fang, Yaosheng Chen, et al.Journal of Medicinal Chemistry|May 28, 2021
Structure-Based Design of Highly Potent Toll-like Receptor 7/8 Dual Agonists for Cancer ImmunotherapyZhisong Wang, Yan Gao, Lei He, et al.Head & Neck|March 11, 2026
Assessment Tools of Radiation Skin Injury in Head and Neck Cancer: A Narrative Review of Preclinical and Clinical StudiesYunhao Chen, Yafang Hong, Yang Zhang, et al.Pageof 34